New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients Post author: Post published:November 23, 2023 Post category:uncategorized Bivalent booster dose enhanced neutralization of Omicron XBB (sub)variants in non-small cell lung cancer (NSCLC) patients. You Might Also Like Significant genetic variations linked to cannabis use disorder identified in major global ancestries November 22, 2023 Prenatal exposure to cannabinoids impacts adult health in rats October 3, 2024 Alarmin molecule identified as therapeutic target for allergic respiratory diseases April 12, 2024
Significant genetic variations linked to cannabis use disorder identified in major global ancestries November 22, 2023